Serono and InDex in Ulcerative Colitis Deal
By Business Review Editor
Pharma Deals Review: Vol 2004 Issue 46 (Table of Contents)
Published: 4 Apr-2004
DOI: 10.3833/pdr.v2004.i46.816 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Serono and InDex Pharmaceuticals entered into licensing agreement for worldwide development and commercialization of InDex’s Kappaproct® for treating ulcerative colitis...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS